Project Report
Characterizing the FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle
Nicholas R. Harrison and Sarah Sheehan
2020
Read More
Comparing Associations of State Reopening Strategies with COVID-19 Burden
Brystana G Kaufman, Rebecca Whitaker, Nirosha Mahendraratnam, Valerie A Smith, Mark McClellan
2020
Read MorePolicy Brief
Monoclonal Antibody Therapies for COVID-19: What Governors Need to Know
National Governors Association, Duke-Margolis Center for Health Policy, COVIDCollaborative
2020
Read MoreComment Letter
CMS Comment Letter on Proposed Coverage Pathway
Mark McClellan, Beena Bhuiyan Khan, Rebecca Ray, Marianne Hamilton Lopez
2020
Read More